The company expects the first batches of the COVID-19 vaccine, JNJ-78436735 ... The average price target represents a 14.23% increase from the last price of $146.07. All those seven equity ...
News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...
The most effective of these were the Pfizer and Moderna ... of this vaccine and urge haste to bring forward its consumer availability to create another strong defense in the ongoing COVID-19 ...
(Moderna and Johnson & Johnson’s shots are still authorized only for adults 18 and older.) Kids younger than 12 are still unable to get a COVID-19 vaccine ... Pfizer's CEO recently said people ...
So much so that Moderna CEO Stéphane Bancel says his staff should be making the most of the investment in AI and using it a lot. More than "a lot." Bancel's suggestion: More than 20 times a day.
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...
opens new tab copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent Office determines whether two of the three Moderna patents at issue are valid, a Massachusetts ...
As NBC News explains: The authors refined their focus to people who got an mRNA Covid vaccine from Pfizer or Moderna and died within 100 days of being vaccinated. Out of 40 deaths that occurred ...
Shah Capital’s decision to launch an activist campaign against Novavax comes as the shares of more successful Covid-19 vaccine makers such as Pfizer, BioNTech and Moderna have fallen as pandemic ...
Google and Alphabet’s CEO Sundar Pichai sat down for a discussion on AI that inevitably focused on the future of search. He explained his view of search and the role of websites ten years from ...
The company reported sales of $167 million, sharply below $1.9 billion a year ago due to evaporating COVID-19 vaccine ... Moderna (MRNA) are on the rise despite first quarter losses. Moderna CEO ...